In 2021,China’s domestically produced coronavirus disease 2019(COVID-19)vaccines received approval from regulatory bodies and were administered worldwide.Due to a low number of infections within China during that per...In 2021,China’s domestically produced coronavirus disease 2019(COVID-19)vaccines received approval from regulatory bodies and were administered worldwide.Due to a low number of infections within China during that period,it became imperative to evaluate the vaccines’real-world effectiveness through international studies.To facilitate this,China CDC launched the COVID-19 Vaccines Evaluation Program(COVEP).This program formed research collaboration agreements with health institutes across five World Health Organization regions,addressing key questions about vaccine performance through ten cooperative agreements.The findings from COVEP projects reinforced confidence,both domestically and globally,in the effectiveness of the vaccines produced in China.Moreover,the outcomes observed internationally were frequently mirrored by later studies conducted within China.COVEP thus pioneered a novel approach for fostering cross-national research collaborations,addressing significant public health issues and exemplifying a framework for international cooperation.This approach is in line with the strategic objectives and other development efforts of China CDC’s national disease control and prevention initiatives.展开更多
基金supported by the Chinese Center for Disease Control and Prevention through the COVID-19 Vaccines Evaluation Program(COVEP).
文摘In 2021,China’s domestically produced coronavirus disease 2019(COVID-19)vaccines received approval from regulatory bodies and were administered worldwide.Due to a low number of infections within China during that period,it became imperative to evaluate the vaccines’real-world effectiveness through international studies.To facilitate this,China CDC launched the COVID-19 Vaccines Evaluation Program(COVEP).This program formed research collaboration agreements with health institutes across five World Health Organization regions,addressing key questions about vaccine performance through ten cooperative agreements.The findings from COVEP projects reinforced confidence,both domestically and globally,in the effectiveness of the vaccines produced in China.Moreover,the outcomes observed internationally were frequently mirrored by later studies conducted within China.COVEP thus pioneered a novel approach for fostering cross-national research collaborations,addressing significant public health issues and exemplifying a framework for international cooperation.This approach is in line with the strategic objectives and other development efforts of China CDC’s national disease control and prevention initiatives.
